It was announced today that big pharma giant Bayer will acquire Monsanto and their poisonous goodies for an estimated $66 billion dollars.
The German pharmaceutical company agreed to buy the American GMO company for $128 a share. The acquisition values Monsanto’s equity at approximately $56 billion, but including debt, the deal is worth nearly $66 billion.
BYPASS THE CENSORS
Sign up to get unfiltered news delivered straight to your inbox.
Balenciaga Pedo-gate Blown WIDE OPEN
Klaus Schwab and George Soros Declare China Must Lead New World Order
Klaus Schwab: ‘God Is Dead’ and the WEF is ‘Acquiring Divine Powers’
‘Passion of the Christ’ Star Claims Hollywood Elite Are Trafficking Children For Adrenochrome
Bill Gates Tells World Leaders ‘Death Panels’ Will Soon Be Required
Justin Bieber: Facial Paralysis Is ‘Punishment’ For Exposing Illuminati Pedophilia
Spanish Royalty Expose Who Really Killed Princess Diana
‘Controlled Opposition’: Dave Chappelle’s Family Say He Was Killed and Cloned by the Illuminati
Michael Jackson Was Murdered for Saying SAME Things As Kanye 13 Years Ago
Error 403: The request cannot be completed because you have exceeded your quota..
Domain code: youtube.quota
Reason code: quotaExceeded
The latest bid offered by Bayer is 22 percent above Monsanto’s closing price on the New York Stock Exchange on Tuesday.
The acquisition of the leading GMO maker will make Bayer the world’s biggest seed and pesticide producer. The takeover is expected to be closely scrutinized by antitrust regulators.
The deal will potentially leave just a few large global players in the crop and seed industry. American conglomerate DuPont reportedly plans to merge with the Dow Chemical Company and China National Chemical Corporation is set to acquire Swiss agribusiness Syngenta.
Last week, Bayer raised its offer aiming to complete the deal that had been negotiated for more than four months.
Monsanto is as one of the world’s leading manufacturers of genetically modified seeds. The company has long been criticized in Europe, with many consumers skeptical of GMO-derived produce.
Bayer has signed a deal that includes a fee of $2 billion should the transaction fail to get regulatory clearance as planned, a source told Reuters. It should be closed by the end of 2017.
Founded over 150 years ago, Bayer made its name by introducing heroin as a cough remedy in 1896 and then aspirin in 1899. The German company has become one the global leaders in the pharmaceutical and chemical industries.
Latest posts by Niamh Harris (see all)
- Greece To Allow Unvaccinated Health Staff To Return To Work - December 5, 2022
- Obama Publicly Mocks ‘Uncle Joe’ Biden - December 5, 2022
- Musk Claims Risk Of His Assassination Is ‘Quite Significant’ Following Release Of ‘Twitter Files’ - December 5, 2022